Identity
- Trade Name
- Poly Rb A-Hu Fibrinogen FDA UDI
- Generic Name
- Fibrinogen (Factor I) assay IVD, antibody FDA UDI
- Device Name
- Polyclonal Rabbit Anti-Human Fibrinogen FDA UDI
- Model / Reference
- A0080 FDA UDI
- Description
- Polyclonal Rabbit Anti-Human Fibrinogen FDA UDI
Identifiers
- Primary DI / UDI-DI
- 05700572000556 FDA UDI
- FDA Product Code
- DAZ FDA UDI
- GMDN Term
- Fibrinogen (Factor I) assay IVD, antibody FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 864.7340 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Dimensions & Sizes
- Size
- Total Volume — 2 Milliliter FDA UDI
Category: Fibrinogen (Factor I) assay IVD, antibody
Poly Rb A-Hu Fibrinogen by Agilent Technologies Singapore Pte Ltd — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Fibrinogen (Factor I) assay IVD, antibody.
- FITC Anti-Fibrinogen Primary Antibody — Ventana Medical Systems · Class I
- IHC — Slmp, LLC · Class I
- Tissue-Tek Genie® — Sakura Finetek USA, Inc · Class I
- Poly Rb A-Hu Fibrinogen/FITC — AGILENT TECHNOLOGIES SINGAPORE PTE LTD · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Agilent Technologies Singapore Pte Ltd
Sources (1)
- FDA UDI b39b4090-470c-4747-94a2-8b2865b9f4b1 36 fields · synced May 30, 2026